Indian pharmas seek to protect their edge

Arguing that India will become a "contract manufacturing center" and "lose its edge," industry groups are seeking restrictions on foreign mergers and acquisitions. A panel of government officials recommended a foreign direct investment cap of 49% for brownfield projects while providing no cap for greenfield investments. But planning commission deputy chairman Montek Singh Ahluwalia said on Monday that he sees "no case for rollback" of FDI in the pharma sector. Story


Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.